Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer
Citation
T. Fukui et al., Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer, MOL UROL, 5(1), 2001, pp. 19-23
Categorie Soggetti
Urology & Nephrology
Journal title
MOLECULAR UROLOGY
SICI code
1091-5362(200121)5:1<19:CEOHTC>2.0.ZU;2-Z
Abstract
Purpose: We examined the expression of mRNA of human telomerase reverse tra
nscriptase (hTERT), a catalytic subunit of the telomerase complex, in bladd
er washings as a tumor marker for the detection of bladder cancer.
Materials and Methods: Bladder washings were obtained from 63 patients. We
examined the expression of hTERT mRNA by the nested reverse transcription-p
olymerase chain reaction (RT-PCR) method and also measured the relative exp
ressions of hTERT mRNA and beta (2)-microglobulin (beta (2)-MG) in these sa
mples by RT-PCR analysis. Correlations between the relative expression of h
TERT mRNA and clinical features were analyzed. We also compared the sensiti
vity of this assay with that of urinary cytology,
Results: By nested RT-PCR, we detected three false-positive cases (11%) in
the control group. Therefore, the relative expression values of hTERT mRNA
and beta (2)-MG correlated strongly with tumor size, but not with multiplic
ity or histologic grade. When the cut-off value of the expression was fixed
at 0.27%, the sensitivity and specificity of this assay were 74% and 93%,
respectively. This assay was more sensitive than urinary cytology for the d
etection of bladder cancer.
Conclusion: These results suggest that the relative expression of hTERT mRN
A in bladder washings is useful in screening for bladder cancer. Relative e
xpression is of assistance in diagnosing bladder cancer.